Shot in the dark: Early Covid-19 vaccine efficacy explained

ReutersPublished: Nov 13, 2020 3:25 AM

This week has seen a flurry of good news from Covid-19 vaccine developers, with Pfizer Inc and BioNTech SE trumpeting early data indicating their mRNA candidate is more than 90 percent effective.

A Russian project came out a day later, touting 92 percent efficacy for the Sputnik V candidate, named after the Soviet-era satellite, based on a smaller data set...

Sabah should be given Covid-19 vaccine supply priority, says MP

YOURSAY | ‘Malaysia should not be held to ransom by a vaccine’

Russia says its Sputnik V Covid-19 vaccine is 92 pct effective

BioNTech to price vaccine below market rates, differentiate between regions

Pfizer's Covid-19 vaccine: MOH to wait for clinical trial data

Pfizer, BioNTech initial vaccine results impress, but scientists remain cautious

Comments0

By posting a comment, you agree to our Commenting Terms and Conditions as stipulated in full here.

Do's and don'ts when posting comments in Malaysiakini

TERMS & CONDITIONS

Foul language, profanity, vulgarity, slanderous, personal attack, threatening, sexually-orientated comments or the use of any method of communication that may violate any law or create needless unpleasantness will not be tolerated. Antisocial behaviour such as "spamming" and "trolling" will be suspended. Violators run the risk of also being blocked permanently.

REPORT VIOLATORS

Please use the report feature that is available below each comment to flag offending comments for our moderators to take action. Do not take matters in your own hands to avoid unpleasant and unnecessary exchanges that may result in your own suspension or ban.

NOTICE

Our commenting system is still under development. We have taken note of feedback provided.

Subscriber-only space: